当前位置:阿仪网 > 生物试剂/抗体/细胞 > 生化试剂 > 其他 > MedChemExpress > 产品展示 > 多肽产品 > Cyclo(RADfK)

Cyclo(RADfK) 是选择性 α(v)β(3) 整合素配体, 广泛用于新血管生成的相关研究。
服务

产品完善度:
更新时间:2026/10/7 8:38:06关注度:2468
关键词标签:多肽产品
支付方式:
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 756500-23-9
MCE 国际站:Cyclo(RADfK)
产品活性:Cyclo(RADfK) 是选择性 α(v)β(3) 整合素配体, 广泛用于新血管生成的相关研究。
研究领域:Cytoskeleton
作用靶点:Integrin
In Vitro: Cyclo(RADfK) is a negative control for the cyclo (-RGDfK-), the RGD peptide. RGD peptides are modulators of cell adhesion and are recognized by several members of the integrin family.
相关产品:Bioactive Compound Library Plus | Macrocyclic Compound Library | Cilengitide | iRGD peptide | MK-0429 | GLPG0187 | E7820 | Cucurbitacin B | ATN-161 trifluoroacetate salt | Leukadherin-1 | RGD Trifluoroacetate | OSU-T315 | Arg-Gly-Asp-Ser | Eptifibatide | TR-14035 | A-205804 | Cyclo(-RGDfK) TFA | Cyclo(RGDyK) trifluoroacetate | GRGDSP TFA | Tirofiban hydrochloride monohydrate | RGD peptide (GRGDNP) (TFA) | Tetrac | BIO5192 hydrate | ICAM-1-IN-1 | Vedolizumab | α2β1 Integrin Ligand Peptide TFA | ILK-IN-3 | Natalizumab | Zaurategrast ethyl ester | BIO5192